The Non-Surgical Solution for Back and Neck Pain

"I believe anyone with a herniated or degenerative disc should try VAX-D first, before surgery."
- Dr. Robert Channey, former Assistant Surgeon General of the United States

What is VAX-D?

VAX-D, or Vertebral Axial Decompression is a non-surgical therapy clinically proven to be a successful conservative treatment for chronic low back pain and sciatica. The treatments are safe and effective without the risks of injections, anesthesia or surgical complications.

For over 20 years, we have shown tremendous success rates in treating patients with degenerative or herniated discs using VAX-D procedures.

Can Vax-D Work for You?

Our newest "Genesis" system VAX-D provides relief for patients suffering from the common causes of low back pain, neck pain, and pain into the legs. VAX-D is the only back treatment device that has been shown to decrease disc pressure in clinical research.

The treatment consists of about 20 daily sessions of about 30-45 minutes each on the Genesis system. A qualified VAX-D practitioner will determine your course of therapy and whether or not you are a candidate for treatment.

What Makes VAX-D Effective?


VAX-D has demonstrated success rates of 75% in clinical studies, in hospitals, and at hundreds of private outpatient clinics, including our clinic at Pollack Health and Wellness!

Vax-D is not to be confused with linear traction. Vax-D has been shown to lengthen and decompress the spine, to relieve pressure on the structures that may be causing chronic lower back pain.

VAX-D Tables Have Been Used in the Treatment of:

  • Sciatica
  • Spinal Stenosis (certain types)
  • Bulging discs/Herniated discs
  • Post-surgical/post-surgery
  • Low back pain
  • Leg pain
  • Mid back pain
  • Degenerative Disc Disease

Call today to see if you are a candidate for VAX-D therapy*, 732-244-0222

Patients with certain conditions, including, but not limited to, current pregnancy, abdominal aortic aneurysm, surgical hardware in the area to be treated, ankylosing spondylitis, spondylolisthesis > 50%, certain spinal infections, pelvic or abdominal cancer, tumors, recent vertebral fracture < 6 months, bone fractures, or severe osteoporosis are not candidates for this therapy.